Evidence map›Paper›PMID 35860628›Full record

ArticleFrontiers in chemistry2022

Abietane-Type Diterpenoids From

Er-Lan Yang, Yong Hou, Guo-Xu Ma, Lin-Jun Zou, Xu-Dong Xu, Hai-Feng Wu, Jun-Shan Yang, Hong-Wan Wei, Cong-Zhao Fan, Zhao-Cui Sun and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Er-Lan YangInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China.
Yong HouInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China.
Guo-Xu MaInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China.
Lin-Jun ZouInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China.
Xu-Dong XuInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China.
Hai-Feng WuInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China.
Jun-Shan YangInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China.
Hong-Wan WeiXinjiang Institute of Chinese and Ethnic Medicine, Urumqi, China.
Cong-Zhao FanXinjiang Institute of Chinese and Ethnic Medicine, Urumqi, China.
Zhao-Cui SunInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China.
Lei-Ling ShiXinjiang Institute of Chinese and Ethnic Medicine, Urumqi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Terpenes possess a wide range of structural features and pharmaceutical activities and are promising for drug candidates. With the aim to find bioactive terpene molecules, eight new compounds were isolated from the medicinal plant

Indexed as

abietane-type diterpenoidsanti-inflammatorydrug candidatesNepeta bracteata Benth.ursane-type triterpenoid

Identifiers

PMID35860628
PMCPMC9289214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.